Clinical Trial Kits Market Size & Growth Analysis to 2030

The global clinical trial kits market is anticipated to register a significant CAGR of over 8% during the forecast period 2021 to 2027. The increasing investment in research and development and the growing number of clinical trials around the world are some major factors driving the market growth. The outbreak of COVID-19 has had a positive impact on the growth of the market. The increasing use of home testing has allowed essential clinical research remotely. The increasing demand for remote services and globalization of clinical trials is further anticipated to boost the market.

Market Drivers:

Increasing number of clinical trials: The pharmaceutical and biotechnology industries are constantly engaged in the development of new drugs and therapies, leading to a rise in the number of clinical trials being conducted worldwide. Clinical trial kits, which include various supplies and materials needed for the collection, processing, and analysis of samples, are essential for the smooth conduct of these trials. The increasing number of clinical trials drives the demand for clinical trial kits.

Growing prevalence of chronic diseases: The global burden of chronic diseases, such as cancer, cardiovascular diseases, and diabetes, is increasing significantly. Clinical trials play a vital role in testing and evaluating new treatments and therapies for these diseases. Clinical trial kits are necessary for collecting patient samples, conducting diagnostic tests, and monitoring treatment efficacy. The growing prevalence of chronic diseases contributes to the demand for clinical trial kits.

Advancements in precision medicine: Precision medicine focuses on tailoring medical treatments to individual patients based on their genetic makeup, lifestyle, and other factors. Clinical trials are crucial for evaluating the efficacy and safety of precision medicine approaches. Clinical trial kits that include specialized tools and assays for genomic testing, biomarker analysis, and personalized diagnostics support the development and implementation of precision medicine. The advancements in precision medicine drive the demand for clinical trial kits.

Regulatory requirements and compliance: Conducting clinical trials requires adherence to stringent regulatory requirements and compliance with ethical guidelines. Clinical trial kits help ensure standardization, accuracy, and quality in sample collection, storage, and analysis. They also facilitate compliance with regulatory guidelines and enable efficient data collection and reporting. The need to comply with regulatory requirements and maintain data integrity drives the demand for clinical trial kits.

Increasing focus on patient-centric clinical trials: Patient-centricity is gaining prominence in the design and conduct of clinical trials. Patient-centric clinical trials aim to improve patient experience, engagement, and participation in research studies. Clinical trial kits that are easy to use, patient-friendly, and minimize patient burden enhance the feasibility and success of patient-centric trials. The increasing focus on patient-centric clinical trials contributes to the demand for clinical trial kits.

Technological advancements in diagnostics and sample collection: Technological advancements in diagnostics, sample collection, and analysis methods have improved the efficiency and accuracy of clinical trials. Clinical trial kits incorporate these advanced technologies, such as point-of-care testing devices, minimally invasive sampling techniques, and digital health solutions, to enhance the speed and reliability of data collection. Technological advancements drive the adoption of innovative clinical trial kits.

Globalization of clinical trials: Clinical trials are increasingly conducted across multiple countries and regions, aiming to include diverse patient populations and leverage different healthcare infrastructures. International clinical trials require standardized and validated clinical trial kits that can be efficiently deployed in various locations. The globalization of clinical trials contributes to the demand for clinical trial kits that can meet international standards and accommodate diverse settings.

Outsourcing of clinical trial services: Many pharmaceutical and biotechnology companies outsource clinical trial services to contract research organizations (CROs) and other specialized service providers. These service providers often rely on clinical trial kits to support their operations, ensuring consistent and reliable sample collection, handling, and analysis. The outsourcing of clinical trial services drives the demand for clinical trial kits.

Market Outlook:

Market Insights:

The global clinical trial kits market is bifurcated into services, phases, and geography. On the basis of services, the market is further segmented into kitting solutions and logistics. The logistic segment dominated the global market in 2020 and accounted to hold the largest market share of over half of the market in terms of revenue. The continuous increase in clinical trials is increasing the pharmaceuticals packaging, which is a major factor to drive the segment growth.

On the basis of phase, the market is bifurcated into Phase I, Phase II, Phase III, and Phase IV. The phase III segment dominated the global clinical trial kits market in 2020 and estimated to hold the largest revenue share of over half of the market. Phase III is the transition period of the chemical to the drug. Many successful outcomes concluded by phase II do not survive phase III, often due to significant side effects of therapeutic efficacy, which is important for comprehensive study.

To know more about the study, request a report sample

The clinical trial kits comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The clinical trial kits market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

• 2018-19 – Historical Year
• 2020 – Base Year
• 2021-2027 – Forecast Period

Market Segmentation:

By Services:

• Kitting Solutions
  • Drugs kits
  • Sample collection kits
• Logistics

By Phase:

• Phase I
• Phase II
• Phase III
• Phase IV

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage:

Geographically, North America dominated the global clinical trial kits market in 2020 and expected to maintain its dominance over the forecast period.  The presence of a large number of pharmaceuticals companies and government supportive regulations are some major factors driving the market growth in the region. The increasing demand for remote services and technological advances are further anticipated to boost the market in North America. On the other hand, the Asia Pacific is accounted to grow at the fastest growth rate over the forecast period owing to the rapidly growing pharmaceuticals industry.

Competitive Assessment:

Some of the major market players operating in the global clinical trial kits market are Q2 Solutions, Thermo Fisher Scientific, Brooks Life Science, Labcorp Drug Development, and Charles River Laboratories. Companies are exploring markets through expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Q2 Solutions
• Thermo Fisher Scientific
• Brooks Life Science
• Labcorp Drug Development
• Charles River Laboratories
• Labconnect
• Precision Medicine Group
• Almac Group
• Alpha Laboratories
• Cerba Research

Key Questions Answered by Clinical Trial Kits Market Report

• Global clinical trial kits market forecasts from 2021-2027
• Regional clinical trial kits market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
• Clinical trial kits submarket forecasts from 2021-2027 covering the market by service, by phase, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis pertaining to clinical trial kits market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level clinical trial kits markets from 2021-2027
• Competitive Landscape and market positioning of top 10 players operating in the clinical trial kits market